The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Rearrangement Status in Lung Cancer

被引：0
作者：
Sullivan, H. C. [1 ]
Siddiqui, M. T. [1 ]
Wang, J. [1 ]
Cohen, C. [1 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1945
引用
收藏
页码：468A / 468A
页数：1
相关论文
共 50 条
  • [21] Ineffectiveness of Crizotinib on Brain Metastases in Two Cases of Lung Adenocarcinoma with EML4-ALK Rearrangement
    Maillet, Denis
    Martel-Lafay, Isabelle
    Arpin, Dominique
    Perol, Maurice
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (04) : E30 - E31
  • [22] EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report
    von Buttlar, Xinyu
    Reuss, Joshua E.
    V. Liu, Stephen
    Kim, Chul
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [23] Clinico-pathologic features of lung cancer with EML4-ALK translocation
    Mitsudomi, T.
    Suda, K.
    Tomizawa, K.
    Yatabe, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] The frequency of EML4-ALK gene rearrangement in primary lung adenocarcinoma cases of Turkish patients
    Kaya, H.
    Bozkurtlar, E.
    Kombak, E.
    Toper, H.
    VIRCHOWS ARCHIV, 2014, 465 : S322 - S322
  • [25] Droplet Digital PCR for Absolute Quantification of EML4-ALK Gene Rearrangement in Lung Adenocarcinoma
    Wang, Qiushi
    Yang, Xin
    He, Yong
    Ma, Qiang
    Lin, Li
    Fu, Ping
    Xiao, Hualiang
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (05) : 515 - 520
  • [26] Codrug Approach for the Potential Treatment of EML4-ALK Positive Lung Cancer
    Garces, Aimie E.
    Al-Hayali, Mohammed
    Lee, Jong Bong
    Li, Jiaxin
    Gershkovich, Pavel
    Bradshaw, Tracey D.
    Stocks, Michael J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (03): : 316 - 321
  • [27] Hope without hype: EML4-ALK inhibition for treatment of lung cancer
    Govindan, Ramaswamy
    LANCET ONCOLOGY, 2011, 12 (11) : 983 - 984
  • [28] Dividing and conquering the variation among variants in EML4-ALK lung cancer
    Bivona, Trever G.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S369 - S370
  • [29] Discovery and clinical application of a novel oncogene, EML4-ALK, in lung cancer
    Mano, Hiroyuki
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S214 - S214
  • [30] A case of primary pulmonary atypical carcinoid with EML4-ALK rearrangement
    Liu, Na
    Wang, Jingjing
    Fu, Xiao
    Zheng, Xiaoqiang
    Gao, Huan
    Tian, Tao
    Ruan, Zhiping
    Yao, Yu
    CANCER BIOLOGY & THERAPY, 2020, 21 (01) : 12 - 16
12345